Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinoembryonic antigen-based vaccines.

John Marshall1

  • 1Department of Developmental Therapeutics, Georgetown University Medical Center, Washington, DC 20007, USA.

Seminars in Oncology
|July 26, 2003
PubMed
Summary

Cancer immunotherapy using carcinoembryonic antigen (CEA) vaccines shows promise. These CEA vaccines effectively stimulate T-cell responses, potentially overcoming immune tolerance for cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remarkable Case of Foreign Bodies in the Stomach and Duodenum, Complete Obstruction of the Bowel and Mechanical Displacement of Organs.

Medical examiner (Philadelphia, Pa.)·2023
Same author

REVISE: re-evaluating the inhibition of stress erosions in the ICU-statistical analysis plan for a randomized trial.

Trials·2023
Same author

Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study.

Metabolites·2023
Same author

Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice.

The Lancet regional health. Europe·2023
Same author

Assessing the safety of new germicidal far-UVC technologies.

Photochemistry and photobiology·2023
Same author

Structure-based design of peptidomimetic inhibitors of PSD-95 with improved affinity for the PDZ3 domain.

FEBS letters·2023

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Carcinoembryonic antigen (CEA) is a tumor-associated glycoprotein overexpressed in various carcinomas.
  • CEA overexpression can promote cancer metastasis and is a serologic marker for malignancy.
  • Immune tolerance to CEA hinders effective cancer immunotherapy.

Purpose of the Study:

  • To review preclinical and clinical studies on CEA-based cancer vaccines.
  • To discuss the efficacy of CEA vaccines in inducing immune responses.
  • To explore strategies for enhancing CEA vaccine effectiveness in cancer immunotherapy.

Main Methods:

  • Review of studies utilizing recombinant CEA-vaccinia virus and ALVAC-CEA vaccines.
  • Analysis of vaccine tolerance and T-cell responses.
  • Investigation of adjuvant strategies including costimulatory molecules and cytokines.

Main Results:

  • CEA vaccines are generally well-tolerated.
  • Vaccines effectively induce CEA-specific cytotoxic T-cell responses.
  • Combination strategies (prime-boost, costimulatory molecules, cytokines) enhance T-cell responses.

Conclusions:

  • CEA-based vaccines are a promising approach for cancer immunotherapy.
  • Overcoming immune tolerance to CEA is achievable with vaccination.
  • Optimized vaccine strategies can significantly boost anti-cancer T-cell activity.

Related Experiment Videos